Fiinu (LON: BANK) has been readmitted to AIM following the acquisition of Poland-based foreign exchange brokerage Everfex. The initial payment of £8m was satisfied by the issue of 80 million shares at 10p each and the rest will depend on performance and be payable via up to 20 million shares at 20p each. Everfex made a pre-tax profit of more than £600,000 for the four months to April 2025. The share price returned 29.8% to 18.5p, which is the highest it has been for three years.
Nortrust Nominees has reduced its stake in oil and gas producer Empyrean Energy (LON: EME) from 6.2% to 3.41%. Last Friday, Empyrean Energy chief executive Tom Kelly died in an accident. The share price recovered 26.1% to 0.0725p.
Synthetic binders developer Aptamer Group (LON: APTA) has launched a biomarker discovery service. Biomarkers are molecular indicators of physiological states, including disease presence and enable targeted drug development. The service will use the company’s own Optimer technology in combination with proteomic analysis and it can generate the binding molecules. This is a fee for service model. The share price
Fusion Antibodies (LON: FAB) has been selected for three follow-on projects to the stable Cell Line Development project under an agreement with a US biotech company. The new contracts are worth $460,000 and $400,000 should be recognised in the year to March 2026. The share price increased 11.5% to 0.925p.
Former Britvic chief executive Simon Litherland has been appointed to the board of wine maker Chapel Down (LON: CDGP). The share price improved 5.95% to 44.5p.
Thor Explorations (LON: THX) announced further drilling results from the Guitry Gold Project in Côte d’Ivoire. There have been 3,000 metres of drilling and the latest assays include thee with significant gold showings, including one showing 8 metres at 14.54g/t gold. The drilling shows mineralisation is open at depth. There are soil anomalies that have not been tested. The share price rose 3.85% to 54p.
Transport software and services provider Tracsis (LON: TRCS) says full year revenues edged up from £81m to £82m, while EBITDA was slightly lower at around £12.6m. Trading improved in the second half. Cash was £23.4m at the end of July 2025, after spending £3m on share buybacks. A new £35m revolving credit facility lasts until July 2030. Changes in the UK rail industry continue to make trading tough and growth is likely to be modest in 2025-26. The full 2024-25 results will be published on 20 November. The share price edged up 2.78% to 370p.
FALLERS
Floorcoverings supplier Victoria (LON: VCP) has completed its refinancing and this will provide additional funding and extended maturity dates. Near-term senior debt has been replaced with £528m of 9.875% Senior Secured Notes due July 2029 and a £130m credit facility that lasts until January 2030. There are £70m of pofit improvements planned. The share price fell 4.58% to 69.75p.